Cara Therapeutics
Cara Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors (KORs).
CARA Stock | Cara Therapeutics Inc Q1 2022 Earnings Call
CARA Stock | Cara Therapeutics Inc Q4 2020 Earnings Call
CARA Stock | Cara Therapeutics Inc Q1 2021 Earnings Call
CARA Stock | Cara Therapeutics Inc. Q2 2020 Earnings Call
CARA Stock | Cara Therapeutics Inc Q3 2021 Earnings Call
CARA Stock | Cara Therapeutics Inc Q2 2021 Earnings Call